How biotech startups are funded, from seed round to IPO
Grants, angels, venture rounds, partnerships, IPOs and the less familiar routes in between, and what each one costs a founder in ownership.
Business & Investing
How the life-science business works: funding, deals, filings and the economics behind new treatments.
Moving from the bench to the business side of biotech
Eight business roles that hire former lab scientists, what each borrows from bench work, and how people make the switch without losing years.
Why most drugs fail between phase 2 and approval
Phase 2 is where most experimental drugs stop. The numbers behind that, the main reasons, and what they mean when you read trial news.